Conciseness

The body is largely dense, high-value specifics — tool names, parameter corrections, fallback chains, data minimums, scoring thresholds — and delegates detail to reference files. The 'Target Evaluation Reasoning Framework' section contains some conceptual explanation Claude could largely derive (e.g., "a target expressed only in the disease-relevant tissue is far safer than one expressed ubiquitously"), which is more than purely lean but less than the noticeably padded score-3 pattern.

Actionability

Guidance is highly concrete and executable in intent: exact tool names, a verified parameter-correction table with a code snippet, explicit fallback chains (e.g., "ChEMBL_get_target_activities fails → GtoPdb_search_ligands → OpenTargets drugs"), and quantified minimums ("20 interactors OR documented explanation", "pLI > 0.9", "IC50 < 1μM"). It falls short of the score-5 anchor because the body itself contains only one code example and the worked call implementations are delegated to a file that is not present in the bundle.

Workflow Clarity

The multi-step process is explicitly sequenced with validation checkpoints: identifier resolution 'always first', Phase 0 'BEFORE calling ANY tool' parameter verification, PATH 0 run 'ALWAYS FIRST', a mandatory completeness audit 'REQUIRED before finalizing', report-first placeholders, and the rule 'NEVER silently skip failed tools. Always document failures and fallbacks.' This matches the score-5 anchor's clear sequence with explicit validation and error-recovery feedback loops (the retry/fallback section).

Progressive Disclosure

Structure is good: an overview body with one-level-deep, clearly signaled references both inline and in an end table (IMPLEMENTATION.md, EVIDENCE_GRADING.md, REPORT_FORMAT.md, REFERENCE.md, EXAMPLES.md). However, none of the five referenced files exist in the bundle (no references/, scripts/, or assets/ directories), so the navigation the body promises cannot actually be followed — a real organization gap that keeps this below the score-5 anchor's 'easy navigation'.

Specificity

The description enumerates multiple concrete capabilities with named data sources — "tissue expression (GTEx, HPA), pathways, protein interactions (STRING), variant landscape (ClinVar, gnomAD), druggability (DGIdb, ChEMBL approved drugs)" — comprehensive and specific rather than generic. It does not match the score-4 anchor's 'minor gaps in coverage' since the listed actions span the skill's full scope.

Completeness

It explicitly answers both questions: 'what' is the list of concrete intelligence-gathering capabilities across named databases, and 'when' is the explicit clause "Use for full target profile reports, target characterization for drug discovery, and 'tell me about target X' queries" with concrete trigger phrases. This matches the score-5 anchor exactly; it is above score 4 because the 'when' is specific and quoted, not merely present.

Trigger Term Quality

Natural trigger phrases are present — "full target profile reports", "target characterization for drug discovery", and the directly quotable user query "tell me about target X" — but common variants a user would say (e.g., "target validation", "what do we know about [target]", "is X druggable") are absent. Good coverage with a few natural terms missing matches the score-4 anchor rather than the comprehensive score-5 anchor.

Distinctiveness Conflict Risk

"Comprehensive drug-target intelligence" with named domain databases (GTEx, STRING, ClinVar, gnomAD, DGIdb, ChEMBL) carves out a clear niche with distinct triggers; minimal conflict risk with generic lookup or literature skills. Not score 4, since no plausible overlap with a closely related skill is identifiable from the description itself.